Medical Office Intervention for Adolescent Drug Use - Attention Study Supplement

NCT00593034 | Completed DMC

• 1 other identifier: R01DA014553-03S1
• Study Type: observational
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

This study will use the CCPT II to assess attention in 12-21 year olds enrolled in a randomized controlled trial of a brief behavioral treatment for substance abuse. This study will describe at baseline levels of attention using a well validated instrument (Connors Continuous Performance Test II) and explore the association between attention levels and substance use. The primary study hypothesis is that lower initial levels of substance use (as measured by percent days abstinent) will be associated with higher attention levels. We envision that this data will inform a better understanding of how attention may modify treatment response.

Conditions

Substance-related Disorders

Keywords

Alcohol abuse; Drug abuse

Outcome Measures

Primary Outcomes (1)

• Score on the Connors Continuous Performance Test II (CCPT II)

  Baseline

Secondary Outcomes (1)

• Percentage of days abstinent

  6 months

Study Arms (1)

1

Participants in this study will be 12-21 year old patients who have been referred to the Adolescent Substance Abuse Program for evaluation of drug or alcohol use and are participating in the parent study, "Medical Office Intervention for Adolescent Drug Abuse."

Eligibility Criteria

• Age: 12 Years - 21 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Participants in this study will be 12-21 year old patients who have been referred to the Adolescent Substance Abuse Program for evaluation of drug or alcohol use and are participating in the parent study, "Medical Office Intervention for Adolescent Drug Abuse."

You may qualify if:

• CRAFFT score of 1 or more
• Have used cannabis, alcohol or another drug on at least two occasions during the 30 days preceding their visit
• Can read and understand English

You may not qualify if:

• Require immediate hospitalization or referral to residential substance abuse treatment
• Will not be available to complete the study assessments over the next 9 months.

Sponsors & Collaborators

• Boston Children's Hospital: lead

Study Sites (1)

Children's Hospital Boston

Boston, Massachusetts, 02115, United States

Location

Related Publications (2)

• Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999 Jun;153(6):591-6. doi: 10.1001/archpedi.153.6.591.

  PMID: 10357299 BACKGROUND

• Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002 Jun;156(6):607-14. doi: 10.1001/archpedi.156.6.607.

  PMID: 12038895 BACKGROUND

Related Links

• Web site for the Center for Adolescent Substance Abuse Research, parent research group for the project.

MeSH Terms

Conditions

Substance-Related Disorders; Alcoholism

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders; Alcohol-Related Disorders

Study Officials

• John R Knight, MD

  Boston Children's Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: January 3, 2008
• First Posted: January 14, 2008
• Study Start: February 1, 2007
• Primary Completion: February 1, 2008
• Study Completion: February 1, 2008
• Last Updated: March 8, 2011

Record last verified: 2011-03

Locations

US (1)